Evidence map›Paper›PMID 35150038›Full record

ArticleMolecular plant pathology2022

Suppression of XopQ-XopX-induced immune responses of rice by the type III effector XopG.

Sohini Deb, C G Gokulan, Rajkanwar Nathawat, Hitendra K Patel, Ramesh V Sonti

Open access · goldAbstract read
In one paragraph

Article in Molecular plant pathology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Pathogens (Basel, Switzerland) · 2026
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Sohini DebCSIR - Centre for Cellular and Molecular Biology (CSIR-CCMB), Hyderabad, India.
C G GokulanCSIR - Centre for Cellular and Molecular Biology (CSIR-CCMB), Hyderabad, India.ORCID 0000-0002-4305-2818
Rajkanwar NathawatCSIR - Centre for Cellular and Molecular Biology (CSIR-CCMB), Hyderabad, India.
Hitendra K PatelCSIR - Centre for Cellular and Molecular Biology (CSIR-CCMB), Hyderabad, India.
Ramesh V SontiCSIR - Centre for Cellular and Molecular Biology (CSIR-CCMB), Hyderabad, India.ORCID 0000-0003-4845-0601
Centre for Cellular and Molecular Biology · INUniversity of Copenhagen · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Effectors that suppress effector-triggered immunity (ETI) are an essential part of the arms race in the co-evolution of bacterial pathogens and their host plants. Xanthomonas oryzae pv. oryzae uses multiple type III secretion system (T3SS) secreted effectors such as XopU, XopV, XopP, XopG, and AvrBs2 to suppress rice immune responses that are induced by the interaction of two other effectors, XopQ and XopX. Here we show that each of these five suppressors can interact individually with both XopQ and XopX. One of the suppressors, XopG, is a predicted metallopeptidase that appears to have been introduced into X. oryzae pv. oryzae by horizontal gene transfer. XopQ and XopX interact with each other in the nucleus while interaction with XopG sequesters them in the cytoplasm. The XopG E76A and XopG E85A mutants are defective in interaction with XopQ and XopX, and are also defective in suppression of XopQ-XopX-mediated immune responses. Both mutations individually affect the virulence-promoting ability of XopG. These results indicate that XopG is important for X. oryzae pv. oryzae virulence and provide insights into the mechanisms by which this protein suppresses ETI in rice.

Indexed as

OryzaXanthomonasBacterial ProteinsImmunityMutationPlant DiseasesVirulenceBacterial Proteinseffectoreffector-triggered immunityresistancericeXanthomonas oryzae pv. oryzaeXopGXopQXopX

Identifiers

PMID35150038
PMCPMC8995061
OpenAlexW4211262471

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.